Trifarotene: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 March 2025

  • curprev 22:0122:01, 13 March 2025 Omid Afkhami-Ardakani talk contribs 4,963 bytes +4,963 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Trifarotene |aOrAn=a |drugClass=retinoid |indicationType=treatment |indication=acne vulgaris in patients 9 years of age and older |adverseReactions=Application site irritation, Application site pruritus (itching), Sunburn |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Trifarotene in adult patients. |offLabelAdultNoGuideSupport=There is lim..."